“Quality-by-Design Approach and Optimization of Risk Factors by Box-Behnken Design in Formulation Development of Aspirin and Glycine Orally Disintegrating Tablet”, J. Sci. Res., vol. 13, no. 3, pp. 935–950, Sep. 2021, doi: 10.3329/jsr.v13i3.51952.